You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • THU0187 Safety of Tofacitinib, An Oral Janus Kinase Inhibitor: Integrated Data Analysis from The Global Chronic Plaque Psoriasis Clinical Trials

Citation Tools

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - non-biologic treatment and small molecules
THU0187 Safety of Tofacitinib, An Oral Janus Kinase Inhibitor: Integrated Data Analysis from The Global Chronic Plaque Psoriasis Clinical Trials

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Langley R, Cohen A, Foley P, et al
THU0187 Safety of Tofacitinib, An Oral Janus Kinase Inhibitor: Integrated Data Analysis from The Global Chronic Plaque Psoriasis Clinical Trials
Annals of the Rheumatic Diseases 2016;75:253.